Abstract:Type 2 diabetes (T2D) has a complex pathophysiology which makes modeling the disease difficult. We aimed to develop a novel model for simulating T2D in vitro, including hyperglycemia, hyperlipidemia, and variably elevated insulin levels targeting muscle cells. We investigated insulin resistance (IR), cellular respiration, mitochondrial morphometry, and the associated function in different T2D-mimicking conditions in rodent skeletal (C2C12) and cardiac (H9C2) myotubes. The physiological controls included 5 mM of glucose with 20 mM of mannitol as osmotic controls. To mimic hyperglycemia, cells were exposed to 25 mM of glucose. Further treatments included insulin, palmitate, or both. After short-term (24 h) or long-term (96 h) exposure, we performed radioactive glucose uptake and mitochondrial function assays. The mitochondrial size and relative frequencies were assessed with morphometric analyses using electron micrographs. C2C12 and H9C2 cells that were treated short- or long-term with insulin and/or palmitate and HG showed IR. C2C12 myotubes exposed to T2D-mimicking conditions showed significantly decreased ATP-linked respiration and spare respiratory capacity and less cytoplasmic area occupied by mitochondria, implying mitochondrial dysfunction. In contrast, the H9C2 myotubes showed elevated ATP-linked and maximal respiration and increased cytoplasmic area occupied by mitochondria, indicating a better adaptation to stress and compensatory lipid oxidation in a T2D environment. Both cell lines displayed elevated fractions of swollen/vacuolated mitochondria after T2D-mimicking treatments. Our stable and reproducible in vitro model of T2D rapidly induced IR, changes in the ATP-linked respiration, shifts in energetic phenotypes, and mitochondrial morphology, which are comparable to the muscles of patients suffering from T2D. Thus, our model should allow for the study of disease mechanisms and potential new targets and allow for the screening of candidate therapeutic compounds.

In vivo models of gestational and type 2 diabetes mellitus characterized by endocrine pancreas cell impairment

Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs

Matching model with mechanism: Appropriate rodent models for studying various aspects of diabetes pathophysiology

Understanding Type 1 Diabetes: Etiology and Models

Animal models for type 1 and type 2 diabetes: advantages and limitations

Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis

Modelling human diabetes ex vivo: a glance at maturity onset diabetes of the young

Nutritional Models of Type 2 Diabetes Mellitus

In Vitro Insulin Resistance Model: A Recent Update

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Review on In-vitro Techniques and In-vivo Animals Models for Screening Diabetes and Diabetic Complications

Goto-Kakizaki Rats: Its Suitability As Non-Obese Diabetic Animal Model For Spontaneous Type 2 Diabetes Mellitus

Modeling and Phenotyping Acute and Chronic Type 2 Diabetes Mellitus In Vitro in Rodent Heart and Skeletal Muscle Cells

Study of the pathogenesis and treatment of diabetes mellitus through animal models

Towards a better understanding of diabetes mellitus using organoid models

Genetics of type 2 diabetes: insight from targeted mouse mutants

Characteristics and Influencing Factors Analysis of Diabetic Animal Models

Experimental animal models for diabetes and its related complications—a review

A novel model of gestational diabetes: Acute high fat high sugar diet results in insulin resistance and beta cell dysfunction during pregnancy in mice

Preclinical Models for Type 1 Diabetes Mellitus - A Practical Approach for Research